1. Home
  2. GTBP vs VMAR Comparison

GTBP vs VMAR Comparison

Compare GTBP & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • VMAR
  • Stock Information
  • Founded
  • GTBP 1965
  • VMAR 1995
  • Country
  • GTBP United States
  • VMAR Canada
  • Employees
  • GTBP N/A
  • VMAR N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • VMAR Marine Transportation
  • Sector
  • GTBP Health Care
  • VMAR Industrials
  • Exchange
  • GTBP Nasdaq
  • VMAR Nasdaq
  • Market Cap
  • GTBP 5.5M
  • VMAR 4.5M
  • IPO Year
  • GTBP N/A
  • VMAR 2020
  • Fundamental
  • Price
  • GTBP $0.95
  • VMAR $1.35
  • Analyst Decision
  • GTBP Strong Buy
  • VMAR
  • Analyst Count
  • GTBP 1
  • VMAR 0
  • Target Price
  • GTBP $11.00
  • VMAR N/A
  • AVG Volume (30 Days)
  • GTBP 292.5K
  • VMAR 1.7M
  • Earning Date
  • GTBP 08-14-2025
  • VMAR 07-11-2025
  • Dividend Yield
  • GTBP N/A
  • VMAR N/A
  • EPS Growth
  • GTBP N/A
  • VMAR N/A
  • EPS
  • GTBP N/A
  • VMAR N/A
  • Revenue
  • GTBP N/A
  • VMAR $1,128,568.00
  • Revenue This Year
  • GTBP N/A
  • VMAR N/A
  • Revenue Next Year
  • GTBP N/A
  • VMAR $264.29
  • P/E Ratio
  • GTBP N/A
  • VMAR N/A
  • Revenue Growth
  • GTBP N/A
  • VMAR N/A
  • 52 Week Low
  • GTBP $0.88
  • VMAR $1.30
  • 52 Week High
  • GTBP $4.10
  • VMAR $267.30
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 26.68
  • VMAR 17.47
  • Support Level
  • GTBP $0.88
  • VMAR $1.30
  • Resistance Level
  • GTBP $0.99
  • VMAR $1.54
  • Average True Range (ATR)
  • GTBP 0.10
  • VMAR 0.12
  • MACD
  • GTBP 0.01
  • VMAR 0.09
  • Stochastic Oscillator
  • GTBP 9.92
  • VMAR 7.94

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About VMAR Vision Marine Technologies Inc.

Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.

Share on Social Networks: